安大略省骨折联络服务中未服用既往处方骨活性药物的患者现获处方
在安大略省骨折联络服务中,比较未服用既往处方骨活性药物与无既往处方史患者的骨活性药物处方率。两组处方率相似(既往处方组73.7% vs 无处方史组70.7%,p=0.157),骨折联络服务为患者提供了启动骨活性药物的二次机会。
要点
- 既往有骨活性药物处方但未服用的患者,骨折联络服务中6个月内处方率为73.7%。
- 无既往骨活性药物处方史的患者,骨折联络服务中6个月内处方率为70.7%。
- 两组处方率差异无统计学意义(p=0.157)。
核心结论
- 大范围辖区层面的骨折联络服务方法为未服用既往处方骨活性药物的患者提供了启动该药物的二次机会。
研究设计与样本
- 在安大略省39家骨折门诊于2017年7月1日至2019年9月15日期间筛查的患者中,纳入筛查时未服用骨活性药物且根据CAROC或FRAX判定为未来骨折高风险者,比较有既往处方史与无既往处方史患者的骨活性药物处方率。
主要发现
- 17575例筛查患者中,符合条件者为有既往处方350例和无既往处方2644例。
- 与无既往处方史患者相比,有既往处方史者年龄更大、女性比例更高、报告既往骨折的比例更高、吸烟比例更低。
- 有既往处方史患者6个月内骨活性药物处方率为73.7%,无既往处方史患者为70.7%,差异无统计学意义(p=0.157)。
关键数值与推荐
- 骨活性药物处方率定义为筛查后6个月内从专科医生或初级保健提供者处获得骨活性药物处方。
- 当专科医生报告不可用时,收集患者自我报告数据。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: In an Ontario fracture liaison service (FLS), we compared medication prescription rates among patients not taking a previously prescribed bone active medication to those with no previous prescription. Prescription rates were similar between these two groups of patients. The FLS provided a secondary opportunity for patients to initiate bone active medication. PURPOSE: We compared bone active medication prescription rates among patients presenting to an Ontario fracture liaison service (FLS) who reported not taking a previously prescribed bone active medication to those with no history of prescription. METHODS: Eligible patients were those screened in 39 fracture clinics between July 1, 2017, and September 15, 2019, who were not taking bone active medication at the time of screening and classified as high risk for future fracture based on CAROC or FRAX. Sociodemographic and clinical risk factor variables were assessed at screening. Bone active medication prescription rate was assessed within 6 months of screening and defined as having received a prescription for the medication from either a specialist or primary care provider. In cases where a specialist report was not available, patient self-reported data were collected. The chi-square test of independence was used to assess differences in prescription rates. RESULTS: Of 17,575 patients screened, eligible patients were 350 with a previous prescription and 2644 without a previous prescription. Compared with patients who reported no previous prescription, those who had a previous prescription were older, more likely to be female and to report a previous fracture, and less likely to smoke. There was no statistically significant difference between the medication prescription rate of patients with a previous prescription (73.7%) compared to patients with no previous prescription (70.7%) (p = 0.157). CONCLUSION: A large jurisdiction-wide FLS approach provided a secondary opportunity to patients who were not taking a previously prescribed bone active medication to initiate that medication.
引用
- Sale JEM, Yang A, Inrig T, et al. Patients not taking a previously prescribed bone active medication now prescribed medication through Ontario FLS. Osteoporos Int. 2022. PMID: 35763074. doi:10.1007/s00198-022-06446-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。